Company: MBIO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001104659-25-009408
Chunk: 193

Company: MUSTANG BIO, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 193
---
 ​ |            Number of 
               Shares 
                  and 
            Nature of 
           Beneficial 
            Ownership |   | Percentage 
         of 
      Total 
    Class A 
     Common 
      Stock | ​ |
| City of Hope National Medical Center    | ​ |              845,385 | ​ |        100 | % |

| (1) | The address of City of Hope National Medical Center is 1500 East Duarte Road, Duarte, California 91010. |

| ​                                       |   | Class A Preferred Stock 
      Beneficially Owned |   |            |   |
| Name and Address of Beneficial Owner(1) | ​ |               Number of 
                  Shares 
                     and 
               Nature of 
              Beneficial 
               Ownership |   | Percentage 
         of 
      Total 
    Class A 
  Preferred 
      Stock | ​ |
| Fortress Biotech, Inc.                  | ​ |                 250,000 | ​ |        100 | % |

| (1) | The address of Fortress Biotech Inc. is c/o Fortress Biotech, Inc., 1111 Kane Concourse, Suite 301, Bay Harbor Islands, Florida 33154. |

120

MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES The following discussion is a summary of certain material U.S. federal income tax consequences of the purchase, ownership and disposition of the shares of common stock and pre-funded warrants and accompanying Warrants or components thereof, which we refer to collectively as the “Securities,” issued pursuant to this offering, but does not purport to be a complete analysis of all potential tax effects. The effects of other U.S. federal tax laws, such as estate and gift tax laws, and any applicable state, local or foreign tax laws are not discussed. This discussion is based on the Internal Revenue Code of 1986, as amended (the “Code”), Treasury Regulations promulgated thereunder, judicial decisions, and published rulings and administrative pronouncements of the U.S. Internal Revenue Service (the “IRS”) in effect as of the date of this offering. These authorities may change or be subject to differing interpretations. Any such change or differing interpretation may be applied retroactively in a manner that could adversely affect a holder of the Securities. We have not sought and will not seek any rulings from the IRS regarding the matters discussed below. There can be no assurance the IRS or a court will not take a contrary position regarding the tax consequences of the purchase